|
|
|
|
To compare the efficacy of high-dose intravenous methylprednisolone with intramuscular ACTH in the treatment of acute relapse in multiple sclerosis,we undertook a double-blind,randomized,controlled study involving 61 patients.There was a marked improvement in both groups in the course of the study,but no difference between them in either the rate of recovery or the final outcome.High-dose IV methylprednisolone is a safe alternative to ACTH in the management of acute relapse in MS. |
|